首页> 美国卫生研究院文献>BioMed Research International >Extranodal NK/T-Cell Lymphoma: Toward the Identification of Clinical Molecular Targets
【2h】

Extranodal NK/T-Cell Lymphoma: Toward the Identification of Clinical Molecular Targets

机译:结外NK / T细胞淋巴瘤:临床分子靶标的鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Extranodal natural killer (NK)/T-cell lymphoma of nasal type (NKTCL) is a malignant disorder of cytotoxic lymphocytes of NK or more rarely T cells associated with clonal Epstein-Barr virus infection. Extranodal NKTCL is rare in Western countries, but in Asia and Central and South America it can account for up to 10% of non-Hodgkin's lymphomas. It is an aggressive neoplasm with very poor prognosis. Although the pathogenesis of extranodal NKTCL remains poorly understood, some insights have been gained in the recent years, especially from genome-wide studies. Based on our own experience and knowledge of the literature, we here review some of the genomic and functional pathway alterations observed in NKTCL that could provide a rationale for the development of innovative therapeutic strategies.
机译:鼻外型自然杀伤(NK)/ T细胞淋巴瘤(NKTCL)是NK细胞毒性淋巴细胞的恶性疾病,或更罕见的是与克隆的爱泼斯坦-巴尔病毒感染相关的T细胞。结外NKTCL在西方国家很少见,但在亚洲,中南美洲,它可占非霍奇金淋巴瘤的10%。这是一种侵袭性肿瘤,预后很差。尽管结外NKTCL的发病机理仍然知之甚少,但近年来,尤其是从全基因组研究中获得了一些见识。基于我们自己的经验和文献知识,在这里我们回顾一些在NKTCL中观察到的基因组和功能途径的改变,这些改变可能为开发创新治疗策略提供理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号